STOCK TITAN

Radnet Inc - RDNT STOCK NEWS

Welcome to our dedicated news page for Radnet (Ticker: RDNT), a resource for investors and traders seeking the latest updates and insights on Radnet.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Radnet's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Radnet's position in the market.

Rhea-AI Summary
RadNet, Inc. (NASDAQ: RDNT) plans to offer $200 million of common stock in a public offering, with an option for an additional $30 million. The proceeds will be used for general corporate purposes and potential acquisitions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.18%
Tags
-
Rhea-AI Summary
RadNet, Inc. (NASDAQ: RDNT) announces key executives to present at Cowen & Company Healthcare Conference.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.26%
Tags
conferences
-
Rhea-AI Summary
RadNet, Inc. (NASDAQ: RDNT) announced that Mark Stolper, EVP and CFO, will present at the Raymond James Institutional Investors Conference. The presentation will be live-streamed and covers the company's diagnostic imaging services.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.61%
Tags
conferences
Rhea-AI Summary
RadNet, Inc. (RDNT) reports record revenue of $420.4 million in Q4 2023, up 9.5% from Q4 2022. Adjusted EBITDA from Imaging Center segment hits $68.3 million, a record high. AI revenue surges by 278.4%. The company forms a Digital Health reporting segment and enters the Houston market through an acquisition. 2024 guidance anticipates revenue, EBITDA, and free cash flow increases.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.14%
Tags
-
Rhea-AI Summary
RadNet, Inc. (NASDAQ: RDNT) announces the acquisition of seven imaging centers in Houston, Texas. The centers generated over $28 million in revenue in 2023, offering a range of diagnostic imaging services.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.11%
Tags
-
Rhea-AI Summary
RadNet, Inc. (NASDAQ: RDNT) partners with JVS SoCal to launch ImagingWorks®, a diagnostic imaging career training program funded by the Berger Family Trust. The program aims to address the shortage of healthcare workers, specifically imaging technologists, by providing comprehensive education, internships, and job placement opportunities. RadNet's President, Dr. Berger, emphasizes the program's impact on expanding the pool of well-trained professionals in the diagnostic imaging industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.1%
Tags
partnership
Rhea-AI Summary
RadNet, Inc. (RDNT) will host a conference call to discuss its fourth quarter 2023 financial results on March 1, 2024. Investors can join the call to learn about the company's performance in providing diagnostic imaging services.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.13%
Tags
-
Rhea-AI Summary
RadNet, Inc. (RDNT) announces the acquisition of seven outpatient imaging centers in Phoenix, Arizona, expanding its services for Evernorth Care Group patients. The acquisition will integrate RadNet's digital health solutions to improve operational workflow and patient experience. The company aims to provide specialized imaging services in oncology, musculoskeletal, cardiac, and vascular and neuroscience to the patients of Evernorth Care Group.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.05%
Tags
-
Rhea-AI Summary
RadNet, Inc. (NASDAQ: RDNT) to Present at 42nd Annual J.P. Morgan Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.41%
Tags
conferences
Rhea-AI Summary
RadNet, Inc. (NASDAQ: RDNT) introduces MammogramNow, a screening mammography service debuting at Walmart Supercenter in Milford, Delaware. The innovative initiative aims to enhance breast health awareness and accessibility, integrating DeepHealth® technology into the Walmart Supercenter environment to provide convenient access to crucial breast cancer screening services.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.51%
Tags
none
Radnet Inc

Nasdaq:RDNT

RDNT Rankings

RDNT Stock Data

3.57B
60.33M
11.46%
75.13%
4.02%
Dental Laboratories
Manufacturing
Link
US
Los Angeles

About RDNT

radnet, inc. is the leading national provider of freestanding, fixed-site diagnostic imaging services in the united states based on the number of locations and annual imaging revenue. radnet has a network of 340+ owned and/or operated outpatient imaging centers. radnet's core markets include california, delaware, maryland, new jersey, and new york. together with affiliated radiologists, and inclusive of full-time and per diem employees and technicians, radnet has a total of approximately 7,300 employees.